Prostaglandins of the E-series inhibit connective tissue proliferation in the liver wound of the rat

被引:4
作者
Arend, A
Aunapuu, M
Masso, R
Selstam, G
机构
[1] Univ Tartu, Dept Anat, EE-51014 Tartu, Estonia
[2] Univ Tartu, Dept Gen & Mol Pathol, EE-51014 Tartu, Estonia
[3] Umea Univ, Div Physiol, Dept Mol Biol, S-90187 Umea, Sweden
关键词
animal model; wound healing; prostaglandins; radioimmunoassay; inflammation; connective tissue; proliferation; liver; rat;
D O I
10.1016/j.aanat.2004.07.001
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The present study was undertaken to relate wound heating of an internal organ to prostaglandins of the E and F series. A small liver wound was induced by a galvanic cauter via the abdominal route under general anesthesia and prostaglandin E-1, E-2 and F-2 alpha were injected twice daily at a dose of 250 mu g/kg. Proliferation of the connective tissue in the liver wound was estimated morphometrically 6 days after liver wound infliction. Levels of prostaglandins E-2 and F-2 alpha were measured in the liver wound as well as in normal liver tissue from adjacent lobes using radioimmunoassay. The results show that exogenous prostaglandins of the E-series suppress connective tissue proliferation. Three minutes after the last prostaglandin E-2 injection, high prostaglandin concentrations were measured both in the tiver wound and in the liver tissue of the adjacent lobe. Prostaglandin F-2 alpha injections had no effect on wound heating. We believe that the rat thermic liver wound model can be used for different studies on wound heating mechanisms and that prostaglandins of the E-series are involved in wound heating in the specific time period studied. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 21 条
[1]   Lipoic acid prevents suppression of connective tissue proliferation in the rat liver induced by n-3 PUFAs - A pilot study [J].
Arend, A ;
Zilmer, M ;
Vihalemm, T ;
Selstam, G ;
Sepp, E .
ANNALS OF NUTRITION AND METABOLISM, 2000, 44 (5-6) :217-222
[2]  
AREND O, 1966, ACTA COMMENTATIONES, V191, P15
[3]  
AREND O, 1960, ARKH PATOL, V4, P56
[4]  
AREND U, 1987, ACTA COMMENTATIONES, V862, P3
[5]  
BOGOVSKI P, 1959, ACTA COMMENTATIONES, V79, P37
[6]   PROSTAGLANDINS AND CHRONIC INFLAMMATION [J].
BONTA, IL ;
PARNHAM, MJ .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (12) :1611-1623
[7]   INTERACTION(S) BETWEEN ESSENTIAL FATTY-ACIDS, EICOSANOIDS, CYTOKINES, GROWTH-FACTORS AND FREE-RADICALS - RELEVANCE TO NEW THERAPEUTIC STRATEGIES IN RHEUMATOID-ARTHRITIS AND OTHER COLLAGEN VASCULAR DISEASES [J].
DAS, UN .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1991, 44 (04) :201-210
[8]   ROLE OF PROSTANOIDS IN THE INFLAMMATORY REACTION AND THEIR THERAPEUTIC POTENTIAL IN THE SKIN [J].
EKERDT, R ;
MULLER, B .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1992, 284 :S18-S21
[9]   Regulation by prostaglandin E2 and histamine of angiogenesis in inflammatory granulation tissue [J].
Ghosh, AK .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2003, 123 (05) :295-303
[10]  
HEDQVIST P, 1991, ADV PROSTAG THROMB L, V21, P537